An interventional study of Intervention Probiotics, Fibruline® Inulin Powder in Gut Health, Bloating and Digestive Discomfort, sponsored by Peach Perfect. Recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Peach Perfect · Not applicable, Interventional, and Treatment
This study will evaluate the effects of the Peachbiotic supplement on gut health in adults experiencing gastrointestinal symptoms. The trial is a single-arm, open-label, virtual study in which all 40 enrolled participants will use the test product daily for 12 weeks.
Participants will take one capsule of the product once daily in the morning with food and will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in gut health outcomes including bloating, digestive comfort, regularity of bowel movements, gasiness, and general well-being.
1,046 studies on the registry are indexed under Constipation; 161 are open to participants now.
This study's planned enrollment of 40 is below the median of 75 across 884 interventional studies indexed under Constipation.
Browse Constipation studies →This is the only study on the registry with Peach Perfect as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dietary Supplement: Intervention Probiotics, Fibruline® Inulin Powder
All participants will use the test product. Participants will answer questionnaires at Baseline, Week 4, Week 8, and Week 12.
Change in Gut Health (GSRS)
Change in gut health assessed via self-reported questionnaires including the Gastrointestinal Symptom Rating Scale (GSRS)
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Gut Health (Bristol Stool Scale)
Change in gut health assessed via self-reported questionnaires including the Bristol Stool Scale
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Bloating
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on bloating
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Digestive Comfort
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on digestive comfort
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Regularity of Bowel Movements
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on regularity of bowel movements
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Gasiness
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on gasiness
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported General Well-Being
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on general well-being
Time frame: Baseline, Week 4, Week 8, and Week 12
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.